Latvia

Latvia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
1.46 (0.17 - 12.10) 2015 Modelled WHO
0.54 (0.46 - 0.61) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.6 (0.52 - 0.68) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.53 - 0.70) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.54 - 0.69) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.53 - 0.70) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.54 - 0.70) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.56 - 0.72) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.58 - 0.74) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.59 - 0.77) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.60 - 0.78) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.71 (0.61 - 0.80) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.63 - 0.82) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.65 - 0.84) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.86) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.67 - 0.88) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.79 (0.68 - 0.88) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.69 - 0.90) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.70 - 0.93) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.72 - 0.95) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.72 - 0.97) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.87 (0.74 - 0.98) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.77 - 1) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.79 - 1.03) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.81 - 1.05) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.81 - 1.07) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.82 - 1.06) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.82 - 1.06) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.81 - 1.05) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.81 - 1.05) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.80 - 1.04) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.49 - 0.65) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.51 (0.06 - 4.68) 2015 Modelled WHO
0.05 (0.04 - 0.06) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.07 (0.06 - 0.09) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.07 (0.06 - 0.09) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.08 (0.06 - 0.10) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.11) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.09 - 0.13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.10 - 0.15) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.15) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.10 - 0.15) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.12 (0.09 - 0.14) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.08 - 0.13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.08 - 0.12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.09 (0.07 - 0.11) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.1 (0.08 - 0.12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.09 - 0.13) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.13 (0.10 - 0.15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.15 (0.12 - 0.19) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.18 (0.14 - 0.22) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.32 (0.26 - 0.39) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.49 - 0.74) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.95 (0.76 - 1.14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (0.98 - 1.48) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.07 - 1.63) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.34 (1.07 - 1.63) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.07 - 1.62) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.33 (1.06 - 1.61) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (1.05 - 1.61) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.29 (1 - 1.61) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.27 (0.12 - 0.56) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
3.6 2017 Survey/reported EMCDDA
1.42 2017 Survey/reported ECDC
2.45 2016 Survey/reported EMCDDA
3.3 2015 Survey/reported EMCDDA
2.14 2014 Survey/reported EMCDDA
2.14 2013 Survey/reported EMCDDA
1.6 2012 Survey/reported EMCDDA
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
10,269 (8,758 - 11,711) 2019 Modelled IHME, GBD 2019 (accessed 2020)
10,464 (8,970 - 11,924) 2019 Modelled IHME, GBD 2019 (accessed 2022)
11,068 (9,530 - 12,493) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11,497 (9,875 - 13,017) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11,675 (10,103 - 13,036) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11,810 (10,147 - 13,247) 2015 Modelled IHME, GBD 2019 (accessed 2022)
12,116 (10,457 - 13,500) 2014 Modelled IHME, GBD 2019 (accessed 2022)
12,552 (10,834 - 13,974) 2013 Modelled IHME, GBD 2019 (accessed 2022)
13,071 (11,357 - 14,623) 2012 Modelled IHME, GBD 2019 (accessed 2022)
13,616 (11,768 - 15,311) 2011 Modelled IHME, GBD 2019 (accessed 2022)
14,074 (12,107 - 15,878) 2010 Modelled IHME, GBD 2019 (accessed 2022)
14,535 (12,565 - 16,336) 2009 Modelled IHME, GBD 2019 (accessed 2022)
15,132 (13,117 - 16,985) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15,789 (13,608 - 17,666) 2007 Modelled IHME, GBD 2019 (accessed 2022)
16,416 (14,064 - 18,404) 2006 Modelled IHME, GBD 2019 (accessed 2022)
16,854 (14,431 - 18,981) 2005 Modelled IHME, GBD 2019 (accessed 2022)
17,233 (14,716 - 19,331) 2004 Modelled IHME, GBD 2019 (accessed 2022)
17,766 (15,196 - 19,984) 2003 Modelled IHME, GBD 2019 (accessed 2022)
18,396 (15,732 - 20,709) 2002 Modelled IHME, GBD 2019 (accessed 2022)
19,045 (16,183 - 21,495) 2001 Modelled IHME, GBD 2019 (accessed 2022)
19,571 (16,499 - 22,176) 2000 Modelled IHME, GBD 2019 (accessed 2022)
20,113 (17,140 - 22,678) 1999 Modelled IHME, GBD 2019 (accessed 2022)
20,848 (17,889 - 23,358) 1998 Modelled IHME, GBD 2019 (accessed 2022)
21,656 (18,703 - 24,239) 1997 Modelled IHME, GBD 2019 (accessed 2022)
22,397 (19,371 - 25,113) 1996 Modelled IHME, GBD 2019 (accessed 2022)
22,908 (19,775 - 25,906) 1995 Modelled IHME, GBD 2019 (accessed 2022)
23,215 (20,049 - 26,067) 1994 Modelled IHME, GBD 2019 (accessed 2022)
23,445 (20,288 - 26,267) 1993 Modelled IHME, GBD 2019 (accessed 2022)
23,549 (20,419 - 26,274) 1992 Modelled IHME, GBD 2019 (accessed 2022)
23,511 (20,391 - 26,353) 1991 Modelled IHME, GBD 2019 (accessed 2022)
23,334 (20,112 - 26,206) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.5 (2.50 - 4.81) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.29 (2.66 - 4) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.46 (2.80 - 4.21) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.94 - 4.49) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.35 (3.47 - 5.36) 1993 Modelled IHME, GBD 2019 (accessed 2022)
5.09 (3.98 - 6.40) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5.08 (3.98 - 6.37) 1995 Modelled IHME, GBD 2019 (accessed 2022)
4.48 (3.53 - 5.57) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.85 (3.83 - 6.04) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.41 (3.48 - 5.56) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.88 (3.83 - 6.12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
4.73 (3.71 - 5.94) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5.49 (4.29 - 6.87) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.4 (4.26 - 6.74) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5.55 (4.37 - 6.96) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5.71 (4.46 - 7.18) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.19 (4.78 - 7.79) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.6 (5.08 - 8.39) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.24 (4.75 - 7.92) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.09 (3.90 - 6.49) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.95 (3.03 - 5.11) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.3 (3.27 - 5.54) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (2.90 - 4.87) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.79 - 4.74) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.66 (2.80 - 4.73) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (2.86 - 4.83) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.59 (2.73 - 4.69) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.45 (2.62 - 4.54) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.47 (2.56 - 4.70) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.49 (2.56 - 4.75) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.50 - 4.81) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
74 2016 Modelled WHO
87 (71 - 106) 1990 Modelled IHME, GBD 2019 (accessed 2022)
92 (74 - 112) 1991 Modelled IHME, GBD 2019 (accessed 2022)
96 (77 - 118) 1992 Modelled IHME, GBD 2019 (accessed 2022)
131 (103 - 165) 1994 Modelled IHME, GBD 2019 (accessed 2022)
114 (91 - 140) 1993 Modelled IHME, GBD 2019 (accessed 2022)
129 (101 - 162) 1995 Modelled IHME, GBD 2019 (accessed 2022)
112 (89 - 140) 1996 Modelled IHME, GBD 2019 (accessed 2022)
109 (86 - 138) 1997 Modelled IHME, GBD 2019 (accessed 2022)
118 (94 - 148) 1998 Modelled IHME, GBD 2019 (accessed 2022)
114 (90 - 143) 1999 Modelled IHME, GBD 2019 (accessed 2022)
116 (91 - 146) 2000 Modelled IHME, GBD 2019 (accessed 2022)
127 (100 - 159) 2001 Modelled IHME, GBD 2019 (accessed 2022)
128 (100 - 160) 2002 Modelled IHME, GBD 2019 (accessed 2022)
128 (101 - 161) 2003 Modelled IHME, GBD 2019 (accessed 2022)
130 (102 - 164) 2004 Modelled IHME, GBD 2019 (accessed 2022)
138 (105 - 175) 2007 Modelled IHME, GBD 2019 (accessed 2022)
140 (108 - 176) 2005 Modelled IHME, GBD 2019 (accessed 2022)
147 (113 - 187) 2006 Modelled IHME, GBD 2019 (accessed 2022)
111 (85 - 141) 2008 Modelled IHME, GBD 2019 (accessed 2022)
92 (70 - 119) 2009 Modelled IHME, GBD 2019 (accessed 2022)
84 (64 - 108) 2010 Modelled IHME, GBD 2019 (accessed 2022)
79 (60 - 102) 2011 Modelled IHME, GBD 2019 (accessed 2022)
75 (57 - 98) 2012 Modelled IHME, GBD 2019 (accessed 2022)
76 (58 - 98) 2013 Modelled IHME, GBD 2019 (accessed 2022)
68 (52 - 89) 2016 Modelled IHME, GBD 2019 (accessed 2022)
71 (54 - 93) 2015 Modelled IHME, GBD 2019 (accessed 2022)
73 (56 - 95) 2014 Modelled IHME, GBD 2019 (accessed 2022)
68 (50 - 92) 2017 Modelled IHME, GBD 2019 (accessed 2022)
67 (49 - 92) 2018 Modelled IHME, GBD 2019 (accessed 2022)
67 (48 - 92) 2019 Modelled IHME, GBD 2019 (accessed 2022)
67 (48 - 92) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
4 (3 - 6) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 6) 1991 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1992 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 1994 Modelled IHME, GBD 2019 (accessed 2022)
5 (3 - 7) 1993 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1996 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1997 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1998 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2000 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1999 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2002 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2004 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 2007 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 12) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 2005 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2008 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2009 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2010 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2011 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2012 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2013 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 2019 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 24) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
97 2009 Survey/reported WHO/UNICEF
98 2008 Survey/reported WHO/UNICEF
97 2007 Survey/reported WHO/UNICEF
97 2006 Survey/reported WHO/UNICEF
98 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
98 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
98 2000 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2019 Survey/reported WHO/UNICEF
99 2020 Survey/reported WHO/UNICEF
94 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
108 2017 Survey/reported EMCDDA, 2019
37 (29 - 47) 2015 Survey/reported EMCDDA 2017
108 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
9 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.2 (1.40 - 2.60) 2015 Modelled Blach et al, 2017
1.93 (1.58 - 2.36) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.58 - 2.36) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.56 - 2.37) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.58 - 2.35) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.94 (1.60 - 2.38) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.60 - 2.36) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.59 - 2.33) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.59 - 2.32) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.58 - 2.32) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.57 - 2.31) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.58 - 2.30) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.58 - 2.31) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.58 - 2.32) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.57 - 2.33) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.57 - 2.34) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.57 - 2.34) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.58 - 2.33) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.57 - 2.35) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.57 - 2.36) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.91 (1.56 - 2.37) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.89 (1.54 - 2.32) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.52 - 2.29) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.84 (1.50 - 2.25) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.47 - 2.24) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.45 - 2.21) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.45 - 2.20) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.45 - 2.20) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.79 (1.45 - 2.19) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.8 (1.45 - 2.21) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.81 (1.46 - 2.23) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.84 (1.51 - 2.25) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
52.49 2016 Survey/reported EMCDDA
48.6 2015 Survey/reported EMCDDA
63.7 2014 Survey/reported EMCDDA
70.1 2013 Survey/reported EMCDDA
74.2 2012 Survey/reported EMCDDA
56.99 2010 Survey/reported EMCDDA
35.94 2009 Survey/reported EMCDDA
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
2.07 (1.34 - 2.40) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
2.4 (1.70 - 3.30) 2008 Survey/reported Tolmane I et al, 2011
2.4 (1.70 - 3.30) 2014 Survey/reported Gower et al, 2014
2.4 (1.70 - 3.30) 2008 Survey/reported ECDC
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
74.4 (67.60 - 81.20) 2014 Modelled Degenhardt L et al, 2017
70.1 (66 - 74) 2013 Survey/reported EMCDDA
85.2 2017 Survey/reported EMCDDA
56.78 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
43,000 (28,000 - 50,000) 2015 Modelled Blach et al, 2017
45,732 (36,894 - 56,438) 1990 Modelled IHME, GBD 2019 (accessed 2022)
45,312 (36,725 - 55,542) 1991 Modelled IHME, GBD 2019 (accessed 2022)
44,917 (36,319 - 55,013) 1992 Modelled IHME, GBD 2019 (accessed 2022)
44,498 (36,070 - 54,694) 1993 Modelled IHME, GBD 2019 (accessed 2022)
44,025 (35,655 - 54,326) 1994 Modelled IHME, GBD 2019 (accessed 2022)
43,583 (35,277 - 53,824) 1995 Modelled IHME, GBD 2019 (accessed 2022)
43,379 (35,139 - 53,503) 1996 Modelled IHME, GBD 2019 (accessed 2022)
43,423 (35,287 - 53,335) 1997 Modelled IHME, GBD 2019 (accessed 2022)
43,535 (35,363 - 53,424) 1998 Modelled IHME, GBD 2019 (accessed 2022)
43,614 (35,562 - 53,608) 1999 Modelled IHME, GBD 2019 (accessed 2022)
43,588 (35,536 - 54,063) 2000 Modelled IHME, GBD 2019 (accessed 2022)
43,325 (35,319 - 53,331) 2001 Modelled IHME, GBD 2019 (accessed 2022)
42,848 (35,143 - 52,403) 2002 Modelled IHME, GBD 2019 (accessed 2022)
42,281 (34,952 - 51,741) 2003 Modelled IHME, GBD 2019 (accessed 2022)
41,712 (34,384 - 51,073) 2004 Modelled IHME, GBD 2019 (accessed 2022)
41,220 (33,863 - 50,559) 2005 Modelled IHME, GBD 2019 (accessed 2022)
40,769 (33,621 - 49,751) 2006 Modelled IHME, GBD 2019 (accessed 2022)
40,292 (33,289 - 49,034) 2007 Modelled IHME, GBD 2019 (accessed 2022)
39,818 (32,847 - 48,297) 2008 Modelled IHME, GBD 2019 (accessed 2022)
39,331 (32,389 - 47,452) 2009 Modelled IHME, GBD 2019 (accessed 2022)
38,806 (31,857 - 46,945) 2010 Modelled IHME, GBD 2019 (accessed 2022)
38,294 (31,565 - 46,322) 2011 Modelled IHME, GBD 2019 (accessed 2022)
37,853 (31,235 - 45,784) 2012 Modelled IHME, GBD 2019 (accessed 2022)
37,470 (31,019 - 45,426) 2013 Modelled IHME, GBD 2019 (accessed 2022)
37,123 (30,642 - 45,333) 2014 Modelled IHME, GBD 2019 (accessed 2022)
36,804 (30,277 - 45,107) 2015 Modelled IHME, GBD 2019 (accessed 2022)
36,468 (29,826 - 44,333) 2016 Modelled IHME, GBD 2019 (accessed 2022)
36,122 (29,106 - 44,189) 2017 Modelled IHME, GBD 2019 (accessed 2022)
35,760 (29,200 - 43,708) 2018 Modelled IHME, GBD 2019 (accessed 2022)
35,192 (28,851 - 43,030) 2019 Modelled IHME, GBD 2019 (accessed 2020)
35,347 (28,992 - 43,191) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
8,300 (5,400 - 9,600) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.09 (3.75 - 6.85) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.16 (1.69 - 2.83) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.32 (1.81 - 3.04) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (1.97 - 3.29) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.69 (2.80 - 4.82) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.1 (2.38 - 4.07) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.78 (2.89 - 4.90) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.48 (2.70 - 4.47) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.55 (2.75 - 4.52) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (3.05 - 5.03) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.02 (3.15 - 5.16) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.9 (3.03 - 4.97) 1999 Modelled IHME, GBD 2019 (accessed 2022)
4.42 (3.45 - 5.66) 2001 Modelled IHME, GBD 2019 (accessed 2022)
4.51 (3.52 - 5.75) 2002 Modelled IHME, GBD 2019 (accessed 2022)
4.59 (3.57 - 5.87) 2003 Modelled IHME, GBD 2019 (accessed 2022)
4.71 (3.70 - 6.02) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.94 (4.56 - 7.66) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.65 (4.35 - 7.32) 2006 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (3.95 - 6.55) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.64 (4.36 - 7.23) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.56 (4.33 - 7.13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.56 (4.33 - 7.15) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.44 (4.25 - 6.98) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.35 (4.19 - 6.88) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.52 (4.34 - 7.10) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.36 (4.19 - 6.92) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.43 (4.25 - 6.97) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.1 (3.97 - 6.60) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.07 (3.83 - 6.72) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.08 (3.78 - 6.87) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.09 (3.75 - 6.85) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
192 2016 Modelled WHO
97 (72 - 131) 2019 Modelled IHME, GBD 2019 (accessed 2022)
97 (72 - 131) 2019 Modelled IHME, GBD 2019 (accessed 2020)
98 (73 - 133) 2018 Modelled IHME, GBD 2019 (accessed 2022)
99 (75 - 131) 2017 Modelled IHME, GBD 2019 (accessed 2022)
100 (78 - 130) 2016 Modelled IHME, GBD 2019 (accessed 2022)
107 (83 - 138) 2015 Modelled IHME, GBD 2019 (accessed 2022)
109 (85 - 140) 2014 Modelled IHME, GBD 2019 (accessed 2022)
112 (88 - 144) 2013 Modelled IHME, GBD 2019 (accessed 2022)
110 (86 - 141) 2012 Modelled IHME, GBD 2019 (accessed 2022)
113 (89 - 146) 2011 Modelled IHME, GBD 2019 (accessed 2022)
118 (92 - 151) 2010 Modelled IHME, GBD 2019 (accessed 2022)
119 (93 - 153) 2009 Modelled IHME, GBD 2019 (accessed 2022)
123 (95 - 157) 2008 Modelled IHME, GBD 2019 (accessed 2022)
131 (101 - 169) 2007 Modelled IHME, GBD 2019 (accessed 2022)
126 (97 - 163) 2006 Modelled IHME, GBD 2019 (accessed 2022)
115 (89 - 148) 2005 Modelled IHME, GBD 2019 (accessed 2022)
107 (84 - 137) 2004 Modelled IHME, GBD 2019 (accessed 2022)
106 (82 - 135) 2003 Modelled IHME, GBD 2019 (accessed 2022)
105 (82 - 134) 2002 Modelled IHME, GBD 2019 (accessed 2022)
104 (81 - 133) 2001 Modelled IHME, GBD 2019 (accessed 2022)
96 (75 - 123) 2000 Modelled IHME, GBD 2019 (accessed 2022)
94 (73 - 120) 1999 Modelled IHME, GBD 2019 (accessed 2022)
96 (75 - 123) 1998 Modelled IHME, GBD 2019 (accessed 2022)
88 (68 - 112) 1997 Modelled IHME, GBD 2019 (accessed 2022)
87 (68 - 112) 1996 Modelled IHME, GBD 2019 (accessed 2022)
96 (73 - 125) 1995 Modelled IHME, GBD 2019 (accessed 2022)
95 (72 - 124) 1994 Modelled IHME, GBD 2019 (accessed 2022)
81 (62 - 106) 1993 Modelled IHME, GBD 2019 (accessed 2022)
67 (52 - 87) 1992 Modelled IHME, GBD 2019 (accessed 2022)
62 (48 - 80) 1991 Modelled IHME, GBD 2019 (accessed 2022)
57 (45 - 75) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
5 (4 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
5 (4 - 7) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 1992 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 1995 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 7) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 10) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1997 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 12) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2008 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 14) 2011 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2012 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2014 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2016 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2017 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
28 (20 - 36) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of persons treated for HCV

National
Download
Value Year Type Source
1,300 2017 Survey/reported ECDC, 2019
1,300 2017 Survey/reported The European Centre for Disease Prevention and Control, 2019
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
108 2017 Survey/reported EMCDDA, 2019
37 (29 - 47) 2015 Survey/reported EMCDDA 2017
108 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
9 2017 Survey/reported EMCDDA, 2019
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes (for risk groups)
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Many (31-60%)
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Hepatitis related deaths (national)

Modelled

HBV
67
2019
(48 - 92)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
97
2019
(72 - 131)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
97 (%)
2009
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
108
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines